<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="article-commentary"><?properties open_access?><?properties manuscript?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-journal-id">9918541288006676</journal-id><journal-id journal-id-type="pubmed-jr-id">52313</journal-id><journal-id journal-id-type="nlm-ta">Cell Signal (Middlet)</journal-id><journal-title-group><journal-title>Cell signaling</journal-title></journal-title-group></journal-meta><article-meta><article-id pub-id-type="pmid">40401196</article-id><article-id pub-id-type="pmc">PMC12094670</article-id><article-id pub-id-type="doi">10.46439/signaling.3.053</article-id><article-id pub-id-type="manuscript">NIHMS2077915</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Insights into early acne pathogenesis: Exploring intercellular dynamics and key dysregulated genes</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Deng</surname><given-names>Min</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Farahani</surname><given-names>Kiana</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Agak</surname><given-names>George W.</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="CR1" ref-type="corresp">*</xref></contrib><aff id="A1"><label>1</label>Division of Dermatology, David Geffen School of Medicine, University of California (UCLA), Los Angeles, CA 90095, USA</aff></contrib-group><author-notes><fn fn-type="con" id="FN1"><p id="P1">Author Contributions</p><p id="P2">Conceiving and Writing, Original Draft Preparation: MD; Figure Visualization: MD, KF; Review and Editing, as well as providing critical suggestions throughout the study: GWA. All authors have read and agreed to the published version of the manuscript.</p></fn><corresp id="CR1"><label>*</label>Author for correspondence: <email>Gagak@mednet.ucla.edu</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>11</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="ppub"><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>21</day><month>5</month><year>2025</year></pub-date><volume>3</volume><issue>1</issue><fpage>32</fpage><lpage>39</lpage><permissions><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri xlink:href="https://www.probiologists.com/article/insights-into-early-acne-pathogenesis-exploring-intercellular-dynamics-and-key-dysregulated-genes"/><related-article related-article-type="commentary-article" id="ra1" xlink:href="11325718" ext-link-type="pmcid"/><abstract id="ABS1"><p id="P3">The comprehensive changes and shared dysregulated signaling pathways in early stage acne remains largely unexplored. In our recently published paper entitled &#x0201c;<italic toggle="yes">Analysis of Intracellular Communication Reveals Consistent Gene Changes Associated with Early-Stage Acne Skin</italic>,&#x0201d; we utilized single-cell RNA sequencing and spatial transcriptomics datasets from acne patients to analyze cell communication. We identified dysregulated genes linked to inflammatory responses and hyperkeratinization. This commentary discusses potential new markers across major skin cell types, including endothelial cells, fibroblasts, lymphocytes, myeloid cells, keratinocytes, and smooth muscle cells. Additionally, we discuss key dysregulated genes in acne lesions, focusing on the intricate interplay between inflammation and hyperkeratinization. Based on our findings, we explore potential FDA-approved treatments targeting two key pathways involved in acne pathogenesis. These insights provide new therapeutic targets for acne treatment.</p></abstract><kwd-group><kwd>Acne vulgaris</kwd><kwd>Cell-cell interaction</kwd><kwd>Early-stage of acne</kwd><kwd>Cell markers in the skin</kwd><kwd>Inflammatory response</kwd><kwd>TREM2 macrophages</kwd><kwd>GRN-SORT1 axis</kwd><kwd>Hyperkeratinization</kwd><kwd>Keratinocyte</kwd><kwd>IL-13-IL13-RA1 axis</kwd></kwd-group></article-meta></front><body><sec id="S1"><title>Commentary</title><p id="P4">Acne vulgaris, the most common skin condition worldwide, affects over 85% of adolescents, with nearly half continuing to experience it into adulthood. The scarring and post-inflammatory hyperpigmentation associated with acne can profoundly impact mental health and self-esteem, underscoring the importance of early and effective treatment [<xref rid="R1" ref-type="bibr">1</xref>].</p><p id="P5">Acne is more than a cosmetic issue; like other chronic inflammatory diseases, it involves complex interactions between host cells, dysregulated signaling pathways, genetic factors, and the microbiota [<xref rid="R2" ref-type="bibr">2</xref>&#x02013;<xref rid="R8" ref-type="bibr">8</xref>]. These dynamic interactions contribute to four key pathological processes in acne-affected skin: inflammation, hyperkeratinization, seborrhea, and the accumulation of <italic toggle="yes">Cutibacterium acnes</italic> (<italic toggle="yes">C. acnes</italic>) within the pilosebaceous unit (PSU) [<xref rid="R9" ref-type="bibr">9</xref>]. Among them, hyperkeratinization leads to clogged pores, while seborrhea, marked by excessive sebum production, creates an environment conducive to <italic toggle="yes">C. acnes</italic> overgrowth. This bacterial proliferation and the eventual rupture of the PSU trigger an immune response, amplifying localized inflammation and further disrupting skin homeostasis. These interconnected processes underscore the complexity of acne as a disease that extends beyond its visible effects on the skin surface [<xref rid="R10" ref-type="bibr">10</xref>].</p><p id="P6">Building on our previous work [<xref rid="R11" ref-type="bibr">11</xref>], this commentary presents new findings on potential markers across major skin cell types, key dysregulated genes linked to inflammation and hyperkeratinization, and the interplay between these processes. These insights enhance our understanding of acne pathogenesis and may guide further research into inflammatory skin diseases.</p></sec><sec id="S2"><title>New Potential Markers for Annotating Major Skin Cell Types in Transcriptomic Data</title><p id="P7">New cell markers are essential for defining and annotating cell types in advanced technologies such as single-cell RNA sequencing (scRNA-seq) and spatial transcriptomic sequencing. These tools provide unprecedented resolution, revealing cellular heterogeneity and, enabling detailed analysis of diversity and dynamic changes that are crucial for understanding the complex process of tissue development. However, accurate cell type annotation remains challenging, as it depends on reliable markers to differentiate closely related cell types and subtypes. The lack of precise markers can lead to misclassification and obscure critical biological insights.</p><p id="P8">In our study, we addressed this challenge by identifying new gene products that function as ligands and receptors in signaling pathways, offering potential cell markers for annotating major skin cell types [<xref rid="R11" ref-type="bibr">11</xref>]. For endothelial cells, we identified the ligands CCL14 and CSF3, along with the receptors ACKR1, LIFR, FLT1, and TGFBR2. In fibroblasts, we found ligands such as CXCL12, PTN, C3, and FGF7, as well as receptors including PDGFRA, SDC2, ACVR1, and FGFR1. Similarly, in lymphocytes, we identified the ligands TGFB1 and CCL5, and the receptors CXCR4, IL-7R, IL-2RG, and ITGB2. For myeloid cells, the ligands NAMPT, CXCL8, IL1B, VEGFA, and CXCL3 were identified alongside receptors CD74, CD44, IL-1R2, and ITGAX. In keratinocytes, we found the ligand AREG and the receptors EGFR and ERBB2, while PDGFA was identified as the ligand in smooth muscle [<xref rid="R11" ref-type="bibr">11</xref>] (<xref rid="F1" ref-type="fig">Figure 1</xref>). These findings reveal critical roles for these genes in signal transduction and cell-specific functions, advancing our ability to annotate and understand the diverse cell types in the skin. To validate these findings, we analyzed two published skin scRNA-seq datasets and plan to use experimental approaches such as multiple channel immunofluorescence [<xref rid="R12" ref-type="bibr">12</xref>,<xref rid="R13" ref-type="bibr">13</xref>] and flow cytometry [<xref rid="R14" ref-type="bibr">14</xref>,<xref rid="R15" ref-type="bibr">15</xref>] to further validate these markers with specific cell types in skin biopsies in a future study. We will use samples from <italic toggle="yes">C. acnes</italic> and squalene-induced acne mouse models [<xref rid="R16" ref-type="bibr">16</xref>], with non-induced mice as controls. Additionally, biopsies from acne patients and healthy controls (individuals without acne) will be analyzed. However, obtaining human samples presents significant challenges due to ethical concerns about scarring, as patients may be reluctant to undergo skin biopsy procedures. Moreover, using the mouse model presents limitations, as acne is a uniquely human disease, and the mouse model cannot fully replicate the complex human pathogenesis of acne [<xref rid="R16" ref-type="bibr">16</xref>].</p><p id="P9">We also included five canonical markers for each cell type. For instance, <italic toggle="yes">LUM</italic> serves as a marker for fibroblasts in both skin and intestine, while KRT14 is included in our marker set for annotating keratinocytes in the heatmap [<xref rid="R11" ref-type="bibr">11</xref>,<xref rid="R17" ref-type="bibr">17</xref>]. Consistent with our data, <italic toggle="yes">KRT14</italic> is a well-established keratinocyte marker and is widely used in transgenic mouse models for epidermal gene knockout studies, such as those investigating Paget&#x02019;s disease [<xref rid="R18" ref-type="bibr">18</xref>]. Integrating our novel markers with these previously identified canonical markers [<xref rid="R19" ref-type="bibr">19</xref>&#x02013;<xref rid="R22" ref-type="bibr">22</xref>] will enhance the accuracy of downstream analyses and establish a robust framework for transcriptomic data (<xref rid="F1" ref-type="fig">Figure 1</xref>).</p></sec><sec id="S3"><title>Key Genes Driving Inflammatory Responses in Acne</title><p id="P10">The inflammatory response is a key component of acne pathogenesis, driven by the interaction of <italic toggle="yes">C. acnes</italic> with host immune pathways. Toll-like receptors 2 (TLR2), predominantly expressed in macrophages surrounding the PSU [<xref rid="R9" ref-type="bibr">9</xref>], is a key mediator in this process. Activation of TLR2 by <italic toggle="yes">C. acnes</italic> triggers the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-&#x003ba;B) signaling pathway. The NF-&#x003ba;B pathway is a central regulator of inflammation and immunity. Upon activation, it triggers a cascade of events, including the phosphorylation and degradation of I&#x003ba;B proteins (inhibitors of NF-&#x003ba;B), which sequester NF-&#x003ba;B in the cytoplasm. Once released, the NF-&#x003ba;B protein complex, comprising subunits such as p65 and p50, translocate to the nucleus. This complex acts as a transcription factor, binding to specific DNA sequences to regulate the expression of genes involved in immune responses and inflammation. In the context of acne, activation of the NF-&#x003ba;B pathway by TLR2 signaling leads to the production of pro-inflammatory cytokines, including IL-12, TNF-&#x003b1;, and IL-8 [<xref rid="R23" ref-type="bibr">23</xref>,<xref rid="R24" ref-type="bibr">24</xref>]. These cytokines contribute to the recruitment and activation of immune cells, amplifying the localized inflammatory response observed in acne lesions.</p><p id="P11">Recent advances have identified key genes that regulate inflammation in immune cells, keratinocytes, and sebocytes, significantly enhancing our understanding of acne pathophysiology. In acne, distinct cytokine networks and cellular functions are orchestrated by different cell types [<xref rid="R25" ref-type="bibr">25</xref>,<xref rid="R26" ref-type="bibr">26</xref>]. <italic toggle="yes">C. acnes</italic> strains activate immune cells to secrete innate cytokines which play critical roles in acne. <italic toggle="yes">C. acnes</italic> activate the NOD-like receptor protein 3 (NLRP3) inflammasome in monocytes, leading to the release of IL-1&#x003b2; and and IL-18 [<xref rid="R27" ref-type="bibr">27</xref>]. Conversely, IL-10, an anti-inflammatory cytokine, is downregulated in acne patients [<xref rid="R28" ref-type="bibr">28</xref>]. The reduction of IL-10 impairs its ability to inhibit macrophage and dendritic cell functions, including antigen presentation and the production of inflammatory mediators such as IL-12, and reactive oxygen species [<xref rid="R27" ref-type="bibr">27</xref>,<xref rid="R28" ref-type="bibr">28</xref>]. Additionally, <italic toggle="yes">C. acnes</italic> induces both Th1 and Th17 responses as evidenced by elevated IFN-&#x003b3; and IL-17 in inflammatory acne lesions [<xref rid="R29" ref-type="bibr">29</xref>,<xref rid="R30" ref-type="bibr">30</xref>]. Our prior studies demonstrated that <italic toggle="yes">C. acnes</italic> ribotypes differentially regulate Th17 responses, with acne-associated strains inducing higher IL-17 levels compared to healthy [<xref rid="R29" ref-type="bibr">29</xref>,<xref rid="R31" ref-type="bibr">31</xref>]. Furthermore, <italic toggle="yes">C. acnes</italic> strains can induce Th17 cells to release antimicrobial extracellular traps which kill bacteria [<xref rid="R32" ref-type="bibr">32</xref>].</p><p id="P12">Interestingly, circadian regulators such as BMAL1 have also been implicated in acne-related inflammation. BMAL1 modulates inflammatory responses in macrophages and keratinocytes, potentially influencing the expression of inflammatory cytokines via the NF-&#x003ba;B/NLRP3 axis [<xref rid="R25" ref-type="bibr">25</xref>]. The NLRP3 pathway plays a pivotal role in innate immunity by detecting cellular stress and harmful stimuli. Activation of NLRP3 triggers the assembly of the NLRP3 inflammasome, a multiprotein complex that promotes the cleavage and release of inflammatory cytokines such as IL-1&#x003b2; and IL-18. Beyond inflammasome activation, the NLRP3 pathway is closely linked to upstream signaling pathways, including NF-&#x003ba;B, which primes NLRP3 by increasing the expression of its components. Collectively, these findings highlight the complex network of genes and signaling pathways, including NF-&#x003ba;B, NLRP3, and associated cytokines that drive the inflammatory processes in acne pathogenesis [<xref rid="R25" ref-type="bibr">25</xref>] (<xref rid="T1" ref-type="table">Table 1</xref> and <xref rid="F2" ref-type="fig">Figure 2</xref>).</p><p id="P13">In keratinocytes, several genes and non-coding RNAs contribute to the inflammatory response in acne. MicroRNAs such as miR-146a and miR-143 regulate TLR2 expression and activate the IRAK1/TRAF6/NF-&#x003ba;B and MAPK [<xref rid="R33" ref-type="bibr">33</xref>,<xref rid="R34" ref-type="bibr">34</xref>]. Interleukin-1 receptor-associated kinase 1 (IRAK1) and TNF receptor-associated factor 6 (TRAF6) are key proteins in the TLR2 signaling cascade. Upon TLR2 activation by microbial components such as <italic toggle="yes">C. acnes</italic>, IRAK1 is recruited to the receptor complex and phosphorylated. This activates TRAF6, a ubiquitin ligase, which triggers a cascade of downstream signaling events that ultimately activate the NF-&#x003ba;B pathway. The MAPK pathway is another critical signal activated by IRAK1 and TRAF6 signaling. This pathway involves three primary kinase families: ERK (extracellular signal-regulated kinase), JNK (c-Jun N-terminal kinase), and p38. In acne, these kinases phosphorylate and activate transcription factors that enhance the expression of genes involved in inflammation, further amplifying the inflammatory response [<xref rid="R33" ref-type="bibr">33</xref>,<xref rid="R34" ref-type="bibr">34</xref>]. MiR-143 decreases the stability of TLR2 mRNA, reducing TLR2 protein levels and modulating inflammation [<xref rid="R33" ref-type="bibr">33</xref>,<xref rid="R34" ref-type="bibr">34</xref>]. Furthermore, the circular RNA hsa_circ_0102678 influences the miR-146a/TRAF6/IRAK1 axis to enhance inflammatory responses in keratinocytes [<xref rid="R35" ref-type="bibr">35</xref>]. Additional regulators such as TNIP1 upregulate multiple inflammatory pathways, including NF-&#x003ba;B, p38, MAPK, and JNK, contributing to keratinocyte-driven inflammation [<xref rid="R36" ref-type="bibr">36</xref>]. Similarly, TNFAIP3 plays a dual regulatory role by modulating both the JNK and NF-&#x003ba;B signaling pathways, leading to altered levels of cytokines and chemokines such as IL-6, CCL5, and IL-8 [<xref rid="R37" ref-type="bibr">37</xref>]. The long non-coding RNA H19, when knocked down, inhibits the miR-196a/TLR2/NF-&#x003ba;B axis, highlighting its pro-inflammatory role [<xref rid="R38" ref-type="bibr">38</xref>]. PAR-2, another key player, upregulates the IL-1&#x003b2;, IL-6, and TNF-&#x003b1; (three central pro-inflammatory cytokines) and matrix metalloproteinases (MMPs), underscoring its contribution to keratinocyte-mediated inflammation [<xref rid="R39" ref-type="bibr">39</xref>] (<xref rid="T1" ref-type="table">Table 1</xref> and <xref rid="F2" ref-type="fig">Figure 2</xref>).</p><p id="P14">In sebocytes, TRPV3 expression is elevated in the facial sebaceous glands of acne patients [<xref rid="R40" ref-type="bibr">40</xref>]. Mechanistically, TRPV3 enhances TLR2 expression by promoting the transcription factor phosphorylated FOS-like antigen-1, which binds to the TLR2 promoter, leading to TLR2 upregulation and activation of downstream NF-&#x003ba;B signaling pathways [<xref rid="R40" ref-type="bibr">40</xref>]. Stimulation of SEB-1 cells with the C. acnes strain HL043PA1 resulted in a significant upregulation of S100A8 expression, while S100A9 levels remained stable. Silencing both S100A8 and S100A9 resulted in a 50% reduction of IL-6 and IL-8 production in <italic toggle="yes">C. acnes</italic>-exposed sebocytes, indicating the proinflammatory function of S100A8/A9 in sebocytes [<xref rid="R26" ref-type="bibr">26</xref>]. Interestingly, the formation of extracellular traps in sebocytes following HL043PA1 treatment was observed [<xref rid="R7" ref-type="bibr">7</xref>], a phenomenon previously described by Agak <italic toggle="yes">et al.</italic> in immune cells such as Th17 cells [<xref rid="R32" ref-type="bibr">32</xref>]. This observation expands our understanding by demonstrating that some non-immune cells, such as sebocytes, can also release extracellular traps as part of their defense against <italic toggle="yes">C. acnes</italic>, suggesting a broader role for these traps in skin immunity (<xref rid="T1" ref-type="table">Table 1</xref> and <xref rid="F2" ref-type="fig">Figure 2</xref>). Additionally, S100A8 and S100A9 have been shown to stimulate keratinocyte proliferation via the MAPK pathway suggesting their involvement in hyperkeratinization [<xref rid="R31" ref-type="bibr">31</xref>]. These findings indicate that S100A8 and S100A9 not only contribute to inflammation but may also play a pivotal role in linking hyperkeratinization and inflammation [<xref rid="R26" ref-type="bibr">26</xref>,<xref rid="R41" ref-type="bibr">41</xref>]. This dual role underscores their potential as key mediators in acne (<xref rid="T1" ref-type="table">Tables 1</xref>, <xref rid="T2" ref-type="table">2</xref>, and <xref rid="F2" ref-type="fig">Figure 2</xref>).</p><p id="P15">In our study, we performed a differential analysis of altered signaling pathways, identifying 26 genes with significantly changed expression levels in acne lesions compared to normal skin [<xref rid="R11" ref-type="bibr">11</xref>]. We then focused on 10 genes predominantly expressed in myeloid cells and lymphocytes due to their strong association with inflammation. Among these, granulin precursor (<italic toggle="yes">GRN</italic>) was consistently dysregulated among all six lesional samples compared to non-lesional samples. Further analysis revealed that <italic toggle="yes">GRN</italic> and its receptor, Sortilin 1 (<italic toggle="yes">SORT1</italic>), were upregulated in TREM2-expressing macrophages [<xref rid="R11" ref-type="bibr">11</xref>]. Treatment with <italic toggle="yes">GRN</italic> led to increased expression of three central pro-inflammatory cytokines and chemokines, including <italic toggle="yes">IL-18</italic>, <italic toggle="yes">CCL5</italic>, and <italic toggle="yes">CXCL21</italic>. These findings suggest that the <italic toggle="yes">GRN-SORT1</italic> axis plays a critical role in amplifying the inflammatory response in <italic toggle="yes">TREM2</italic> macrophages, potentially exacerbating inflammation in acne lesions [<xref rid="R11" ref-type="bibr">11</xref>]. Consistent with our study, <italic toggle="yes">GRN</italic> was primarily expressed in macrophages across multiple organs, including the brain [<xref rid="R42" ref-type="bibr">42</xref>], pancreas [<xref rid="R43" ref-type="bibr">43</xref>], and liver [<xref rid="R44" ref-type="bibr">44</xref>], indicating its critical role in macrophage function. Further research is needed to explore <italic toggle="yes">its</italic> contribution to acne formation <italic toggle="yes">in vivo</italic>.</p></sec><sec id="S4"><title>The Intersection of Hyperkeratinization and Inflammation in Acne</title><p id="P16">Hyperkeratinization in acne involves an abnormal increase in keratin production within hair follicles, leading to clogged pores that set the stage for comedone formation. This process is triggered by hormonal shifts, especially during adolescence, which increase keratinocyte proliferation and disrupt normal desquamation [<xref rid="R45" ref-type="bibr">45</xref>]. As keratin and sebum accumulate within the follicle, they create an occlusive environment that not only obstructs the pore but also traps <italic toggle="yes">C. acnes</italic> which thrives in lipid-rich conditions [<xref rid="R10" ref-type="bibr">10</xref>]. In the context of acne, key signaling pathways, including the MAPK and PI3K/AKT/FoxO1 axes, are implicated in keratinocyte hyperproliferation, which can lead to hyperkeratinization [<xref rid="R45" ref-type="bibr">45</xref>]. For example, IGF-1 and IL-8 activate AKT signaling to regulate FoxO1 activity, while downregulation of FoxO1 results in increased keratinocyte proliferation and excessive keratin production, further promoting follicular occlusion [<xref rid="R46" ref-type="bibr">46</xref>&#x02013;<xref rid="R48" ref-type="bibr">48</xref>] (<xref rid="T2" ref-type="table">Table 2</xref> and <xref rid="F2" ref-type="fig">Figure 2</xref>). Beyond their function in hyperkeratinization, keratinocytes also actively mediate immune signaling [<xref rid="R49" ref-type="bibr">49</xref>]. Upon exposure to <italic toggle="yes">C. acnes</italic>, keratinocytes release three central pro-inflammatory cytokines, signaling immune cells to migrate to the follicle [<xref rid="R49" ref-type="bibr">49</xref>]. This immune recruitment promotes inflammation, transforming a non-inflammatory comedone into a papule or pustule [<xref rid="R10" ref-type="bibr">10</xref>]. Additionally, keratinocytes produce antimicrobial peptides (AMPs), including LL-37 and &#x003b2;-defensin, which may help counteract <italic toggle="yes">C. acnes</italic> growth [<xref rid="R50" ref-type="bibr">50</xref>]. However, while these AMPs are protective in the skin, they also exacerbate local inflammation through stimulating cytokine/chemokine production and participate in wound healing by promoting keratinocyte migration and proliferation, creating a cycle in which the immune response perpetuates follicular hyperkeratinization and inflammation, highlighting the intricate interplay between these processes [<xref rid="R51" ref-type="bibr">51</xref>].</p><p id="P17">Hyperkeratinization is fundamentally driven by the dysregulation of keratinocyte signaling pathways. Recent research, including our own analysis of published scRNA-seq datasets, identified the <italic toggle="yes">IL-13-IL13RA1</italic> axis&#x02014;a critical component of the type 2 immune pathway&#x02014;as a key modulator of keratinocyte function in acne [<xref rid="R11" ref-type="bibr">11</xref>]. Activation of this pathway disrupts the expression of essential differentiation genes such as KRT16, KRT17, and FLG, leading to impaired keratinocyte differentiation and abnormal keratin accumulation [<xref rid="R11" ref-type="bibr">11</xref>].</p><p id="P18">The <italic toggle="yes">IL-13-IL13RA1</italic> axis may influence acne through multiple mechanisms. It regulates lipid metabolism in sebocytes [<xref rid="R52" ref-type="bibr">52</xref>], impairs skin barrier function by downregulating <italic toggle="yes">FLG</italic> expression [<xref rid="R53" ref-type="bibr">53</xref>], and contributes to tissue remodeling and fibrosis [<xref rid="R54" ref-type="bibr">54</xref>]. As <italic toggle="yes">IL-13</italic> is secreted by mast cells, NKT cells, T cells, and neutrophils [<xref rid="R11" ref-type="bibr">11</xref>], this pathway links immune signaling to hyperkeratinization. These findings suggest that immune polarization towards a type 2 response may promote keratinocyte proliferation and play a role in the development of acne lesions.</p></sec><sec id="S5"><title>Connecting Acne Pathogenesis to Therapeutic Strategies</title><p id="P19">Based on our findings, we discuss the potential FDA-approved treatments targeting two key pathways identified in acne pathogenesis. One promising clinical application involves dupilumab, an FDA-approved monoclonal antibody that inhibits IL-13 and IL-4 signaling by blocking the IL-4 receptor alpha subunit. While dupilumab is approved for the treatment of atopic dermatitis [<xref rid="R55" ref-type="bibr">55</xref>], asthma [<xref rid="R56" ref-type="bibr">56</xref>], and chronic rhinosinusitis [<xref rid="R57" ref-type="bibr">57</xref>] with nasal polyps, it holds significant potential for treating inflammatory acne. By targeting IL-13, dupilumab may reduce inflammation, restore skin barrier function, and regulate sebocyte activity, offering a novel approach to mitigating acne pathogenesis through modulation of the IL-13-IL13RA1 axis.</p><p id="P20">Currently, there are no FDA-approved treatments specifically targeting GRN or its receptor SORT1. However, targeting the downstream cytokines regulated by the GRN-SORT1 axis could present a promising therapeutic strategy. The GRN-SORT1 axis influences several pro-inflammatory mediators, including the cytokines IL-1&#x003b2;, TNF-&#x003b1;, IL-6, IL-18 and the chemokines CCL5, and CXCL2 [<xref rid="R11" ref-type="bibr">11</xref>]. For example, Maraviroc, an FDA-approved CCR5 antagonist for HIV, blocks the receptor for CCL5 [<xref rid="R58" ref-type="bibr">58</xref>] and may reduce the chemotactic effects of CCL5 in acne lesions. Similarly, TNF-&#x003b1; inhibitors such as Infliximab, Adalimumab, and Etanercept, widely used in the treatment of autoimmune diseases such as rheumatoid arthritis [<xref rid="R59" ref-type="bibr">59</xref>], can help reduce inflammation by inhibiting TNF-&#x003b1; signaling. IL-6 receptor antagonists, Tocilizumab and Sarilumab, approved for conditions such as rheumatoid arthritis [<xref rid="R60" ref-type="bibr">60</xref>], could also offer potential benefits in reducing inflammation in acne. While these therapies were developed for other inflammatory conditions, they provide a foundation for repurposing existing treatments to target the inflammatory pathways that contribute to acne. Notably, IL-1&#x003b2; inhibitors, such as Anakinra and Canakinumab, have shown promise in treating acne [<xref rid="R61" ref-type="bibr">61</xref>].</p><p id="P21">Existing FDA-approved therapies targeting the cytokines above present a potential strategy for treating acne. Future clinical research may further validate their efficacy in acne management.</p></sec><sec id="S6"><title>Conclusion</title><p id="P22">In summary, our findings highlight the importance of understanding cellular communication within acne lesions and identifying novel markers and dysregulated genes that differentiate healthy and acne-prone skin. We also discussed potential FDA-approved treatments targeting two key pathways involved in acne pathogenesis. These insights reveal critical signaling pathways and offer new therapeutic targets for acne treatment.</p></sec></body><back><ack id="S7"><title>Acknowledgments</title><p id="P23">We thank Sarowar Jahan MG and Keshvad Hedayatyanfard from UCLA for their valuable discussions. This work was supported by NIH grants R01AR081337 (GWA).</p></ack><fn-group><fn fn-type="COI-statement" id="FN2"><p id="P24">Conflicts of Interest</p><p id="P25">The authors state no conflict of interest.</p></fn></fn-group><glossary><title>Abbreviations:</title><def-list><def-item><term>C. acnes</term><def><p id="P26">Cutibacterium acnes</p></def></def-item><def-item><term>scRNA-seq</term><def><p id="P27">Single-cell RNA sequencing</p></def></def-item><def-item><term>SORT1</term><def><p id="P28">Sortilin 1</p></def></def-item><def-item><term>TLRs</term><def><p id="P29">Toll-like receptors</p></def></def-item><def-item><term>NF-&#x003ba;B Signaling Pathway</term><def><p id="P30">Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B cells Signaling Pathway</p></def></def-item><def-item><term>NLRP3</term><def><p id="P31">NOD-like Receptor Protein 3</p></def></def-item><def-item><term>MAPK Pathway</term><def><p id="P32">Mitogen-Activated Protein Kinase Signaling Pathway</p></def></def-item><def-item><term>AMPs</term><def><p id="P33">Antimicrobial Peptides</p></def></def-item><def-item><term>HPK</term><def><p id="P34">Human Primary Keratinocyte</p></def></def-item><def-item><term>NHEK</term><def><p id="P35">Normal Human Epidermal Keratinocytes</p></def></def-item><def-item><term>HPV-KER</term><def><p id="P36">Human Papillomavirus-Immortalized Keratinocyte</p></def></def-item><def-item><term>PBMCs</term><def><p id="P37">Peripheral Blood Mononuclear Cells</p></def></def-item><def-item><term>GRN</term><def><p id="P38">Granulin Precursor</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="R1"><label>1.</label><mixed-citation publication-type="journal"><name><surname>Reynolds</surname><given-names>RV</given-names></name>, <name><surname>Yeung</surname><given-names>H</given-names></name>, <name><surname>Cheng</surname><given-names>CE</given-names></name>, <name><surname>Cook-Bolden</surname><given-names>F</given-names></name>, <name><surname>Desai</surname><given-names>SR</given-names></name>, <name><surname>Druby</surname><given-names>KM</given-names></name>, <etal/>
<article-title>Guidelines of care for the management of acne vulgaris</article-title>. <source>J Am Acad Dermatol</source>. <year>2024</year>
<month>May</month>;<volume>90</volume>(<issue>5</issue>):<fpage>1006.e1</fpage>&#x02013;<lpage>1006.e30</lpage>.</mixed-citation></ref><ref id="R2"><label>2.</label><mixed-citation publication-type="journal"><name><surname>S&#x000e1;nchez-Pellicer</surname><given-names>P</given-names></name>, <name><surname>Navarro-Moratalla</surname><given-names>L</given-names></name>, <name><surname>N&#x000fa;&#x000f1;ez-Delegido</surname><given-names>E</given-names></name>, <name><surname>Ruzafa-Costas</surname><given-names>B</given-names></name>, <name><surname>Ag&#x000fc;era-Santos</surname><given-names>J</given-names></name>, <name><surname>Navarro-L&#x000f3;pez</surname><given-names>V</given-names></name>. <article-title>Acne, Microbiome, and Probiotics: The Gut-Skin Axis</article-title>. <source>Microorganisms</source>. <year>2022</year>
<month>Jun</month>
<day>27</day>;<volume>10</volume>(<issue>7</issue>):<fpage>1303</fpage>.<pub-id pub-id-type="pmid">35889022</pub-id>
</mixed-citation></ref><ref id="R3"><label>3.</label><mixed-citation publication-type="journal"><name><surname>Yang</surname><given-names>X</given-names></name>, <name><surname>Li</surname><given-names>G</given-names></name>, <name><surname>Lou</surname><given-names>P</given-names></name>, <name><surname>Zhang</surname><given-names>M</given-names></name>, <name><surname>Yao</surname><given-names>K</given-names></name>, <name><surname>Xiao</surname><given-names>J</given-names></name>, <etal/>
<article-title>Excessive nucleic acid R-loops induce mitochondria-dependent epithelial cell necroptosis and drive spontaneous intestinal inflammation</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2024</year>
<month>Jan</month>
<day>2</day>;<volume>121</volume>(<issue>1</issue>):<fpage>e2307395120</fpage>.<pub-id pub-id-type="pmid">38157451</pub-id>
</mixed-citation></ref><ref id="R4"><label>4.</label><mixed-citation publication-type="journal"><name><surname>Yu</surname><given-names>G</given-names></name>, <name><surname>Wang</surname><given-names>F</given-names></name>, <name><surname>You</surname><given-names>M</given-names></name>, <name><surname>Xu</surname><given-names>T</given-names></name>, <name><surname>Shao</surname><given-names>C</given-names></name>, <name><surname>Liu</surname><given-names>Y</given-names></name>, <etal/>
<article-title>TCF-1 deficiency influences the composition of intestinal microbiota and enhances susceptibility to colonic inflammation</article-title>. <source>Protein Cell</source>. <year>2020</year>
<month>May</month>;<volume>11</volume>(<issue>5</issue>):<fpage>380</fpage>&#x02013;<lpage>86</lpage>.<pub-id pub-id-type="pmid">31970666</pub-id>
</mixed-citation></ref><ref id="R5"><label>5.</label><mixed-citation publication-type="journal"><name><surname>Deng</surname><given-names>M</given-names></name>, <name><surname>Wu</surname><given-names>X</given-names></name>, <name><surname>Duan</surname><given-names>X</given-names></name>, <name><surname>Xu</surname><given-names>J</given-names></name>, <name><surname>Yang</surname><given-names>X</given-names></name>, <name><surname>Sheng</surname><given-names>X</given-names></name>, <etal/>
<article-title>Lactobacillus paracasei L9 improves colitis by expanding butyrate-producing bacteria that inhibit the IL-6/STAT3 signaling pathway</article-title>. <source>Food Funct</source>. <year>2021</year>
<month>Nov</month>
<day>1</day>;<volume>12</volume>(<issue>21</issue>):<fpage>10700</fpage>&#x02013;<lpage>13</lpage>.<pub-id pub-id-type="pmid">34605504</pub-id>
</mixed-citation></ref><ref id="R6"><label>6.</label><mixed-citation publication-type="journal"><name><surname>Zhong</surname><given-names>Y</given-names></name>, <name><surname>Wang</surname><given-names>F</given-names></name>, <name><surname>Meng</surname><given-names>X</given-names></name>, <name><surname>Zhou</surname><given-names>L</given-names></name>. <article-title>The associations between gut microbiota and inflammatory skin diseases: a bi-directional two-sample Mendelian randomization study</article-title>. <source>Front Immunol</source>. <year>2024</year>
<month>Feb</month>
<day>2</day>;<volume>15</volume>:<fpage>1297240</fpage>.<pub-id pub-id-type="pmid">38370414</pub-id>
</mixed-citation></ref><ref id="R7"><label>7.</label><mixed-citation publication-type="journal"><name><surname>Kheshvadjian</surname><given-names>AR</given-names></name>, <name><surname>Deng</surname><given-names>M</given-names></name>, <name><surname>Qin</surname><given-names>M</given-names></name>, <name><surname>To</surname><given-names>T</given-names></name>, <name><surname>Brewer</surname><given-names>GM</given-names></name>, <name><surname>Odhiambo</surname><given-names>WO</given-names></name>, <etal/>
<article-title>462 Trapped in brilliance: Unveiling sebocytes&#x02019; antimicrobial repertoire</article-title>. <source>Journal of Investigative Dermatology</source>. <year>2024</year>
<month>Aug</month>
<day>1</day>;<volume>144</volume>(<issue>8</issue>):<fpage>S80</fpage>.</mixed-citation></ref><ref id="R8"><label>8.</label><mixed-citation publication-type="journal"><name><surname>Xu</surname><given-names>J</given-names></name>, <name><surname>Tang</surname><given-names>Y</given-names></name>, <name><surname>Sheng</surname><given-names>X</given-names></name>, <name><surname>Tian</surname><given-names>Y</given-names></name>, <name><surname>Deng</surname><given-names>M</given-names></name>, <name><surname>Du</surname><given-names>S</given-names></name>, <etal/>
<article-title>Secreted stromal protein ISLR promotes intestinal regeneration by suppressing epithelial Hippo signaling</article-title>. <source>EMBO J</source>. <year>2020</year>
<month>Apr</month>
<day>1</day>;<volume>39</volume>(<issue>7</issue>):<fpage>e103255</fpage>.<pub-id pub-id-type="pmid">32128839</pub-id>
</mixed-citation></ref><ref id="R9"><label>9.</label><mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>J</given-names></name>
<article-title>Review of the innate immune response in acne vulgaris: activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses</article-title>. <source>Dermatology</source>. <year>2005</year>;<volume>211</volume>(<issue>3</issue>):<fpage>193</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">16205063</pub-id>
</mixed-citation></ref><ref id="R10"><label>10.</label><mixed-citation publication-type="journal"><name><surname>Moradi Tuchayi</surname><given-names>S</given-names></name>, <name><surname>Makrantonaki</surname><given-names>E</given-names></name>, <name><surname>Ganceviciene</surname><given-names>R</given-names></name>, <name><surname>Dessinioti</surname><given-names>C</given-names></name>, <name><surname>Feldman</surname><given-names>SR</given-names></name>, <name><surname>Zouboulis</surname><given-names>CC</given-names></name>. <article-title>Acne vulgaris</article-title>. <source>Nat Rev Dis Primers</source>. <year>2015</year>
<month>Sep</month>
<day>17</day>;<volume>1</volume>:<fpage>15029</fpage>.<pub-id pub-id-type="pmid">27189872</pub-id>
</mixed-citation></ref><ref id="R11"><label>11.</label><mixed-citation publication-type="journal"><name><surname>Deng</surname><given-names>M</given-names></name>, <name><surname>Odhiambo</surname><given-names>WO</given-names></name>, <name><surname>Qin</surname><given-names>M</given-names></name>, <name><surname>To</surname><given-names>TT</given-names></name>, <name><surname>Brewer</surname><given-names>GM</given-names></name>, <name><surname>Kheshvadjian</surname><given-names>AR</given-names></name>, <etal/>
<article-title>Analysis of intracellular communication reveals consistent gene changes associated with early-stage acne skin</article-title>. <source>Cell Commun Signal</source>. <year>2024</year>
<month>Aug</month>
<day>14</day>;<volume>22</volume>(<issue>1</issue>):<fpage>400</fpage>.<pub-id pub-id-type="pmid">39143467</pub-id>
</mixed-citation></ref><ref id="R12"><label>12.</label><mixed-citation publication-type="journal"><name><surname>Gu</surname><given-names>W</given-names></name>, <name><surname>Huang</surname><given-names>X</given-names></name>, <name><surname>Singh</surname><given-names>PNP</given-names></name>, <name><surname>Li</surname><given-names>S</given-names></name>, <name><surname>Lan</surname><given-names>Y</given-names></name>, <name><surname>Deng</surname><given-names>M</given-names></name>, <etal/>
<article-title>A MTA2-SATB2 chromatin complex restrains colonic plasticity toward small intestine by retaining HNF4A at colonic chromatin</article-title>. <source>Nat Commun</source>. <year>2024</year>
<month>Apr</month>
<day>27</day>;<volume>15</volume>(<issue>1</issue>):<fpage>3595</fpage>.<pub-id pub-id-type="pmid">38678016</pub-id>
</mixed-citation></ref><ref id="R13"><label>13.</label><mixed-citation publication-type="journal"><name><surname>Wu</surname><given-names>X</given-names></name>, <name><surname>Wang</surname><given-names>S</given-names></name>, <name><surname>Pan</surname><given-names>Y</given-names></name>, <name><surname>Li</surname><given-names>M</given-names></name>, <name><surname>Song</surname><given-names>M</given-names></name>, <name><surname>Zhang</surname><given-names>H</given-names></name>, <etal/>
<article-title>m6A Reader PRRC2A Promotes Colorectal Cancer Progression via CK1&#x003b5;-Mediated Activation of WNT and YAP Signaling Pathways</article-title>. <source>Adv Sci (Weinh)</source>. <year>2024</year>
<month>Nov</month>
<volume>24</volume>:<fpage>e2406935</fpage>.</mixed-citation></ref><ref id="R14"><label>14.</label><mixed-citation publication-type="journal"><name><surname>Sheng</surname><given-names>X</given-names></name>, <name><surname>Lin</surname><given-names>Z</given-names></name>, <name><surname>Lv</surname><given-names>C</given-names></name>, <name><surname>Shao</surname><given-names>C</given-names></name>, <name><surname>Bi</surname><given-names>X</given-names></name>, <name><surname>Deng</surname><given-names>M</given-names></name>, <etal/>
<article-title>Cycling Stem Cells Are Radioresistant and Regenerate the Intestine</article-title>. <source>Cell Rep</source>. <year>2020</year>
<month>Jul</month>
<day>28</day>;<volume>32</volume>(<issue>4</issue>):<fpage>107952</fpage>.<pub-id pub-id-type="pmid">32726617</pub-id>
</mixed-citation></ref><ref id="R15"><label>15.</label><mixed-citation publication-type="journal"><name><surname>Yang</surname><given-names>X</given-names></name>, <name><surname>Li</surname><given-names>G</given-names></name>, <name><surname>Tian</surname><given-names>Y</given-names></name>, <name><surname>Wang</surname><given-names>X</given-names></name>, <name><surname>Xu</surname><given-names>J</given-names></name>, <name><surname>Liu</surname><given-names>R</given-names></name>, <etal/>
<article-title>Identifying the E2F3-MEX3A-KLF4 signaling axis that sustains cancer cells in undifferentiated and proliferative state</article-title>. <source>Theranostics</source>. <year>2022</year>
<month>Sep</month>
<day>25</day>;<volume>12</volume>(<issue>16</issue>):<fpage>6865</fpage>&#x02013;<lpage>82</lpage>.<pub-id pub-id-type="pmid">36276637</pub-id>
</mixed-citation></ref><ref id="R16"><label>16.</label><mixed-citation publication-type="journal"><name><surname>O&#x02019;Neill</surname><given-names>AM</given-names></name>, <name><surname>Liggins</surname><given-names>MC</given-names></name>, <name><surname>Seidman</surname><given-names>JS</given-names></name>, <name><surname>Do</surname><given-names>TH</given-names></name>, <name><surname>Li</surname><given-names>F</given-names></name>, <name><surname>Cavagnero</surname><given-names>KJ</given-names></name>, <etal/>
<article-title>Antimicrobial production by perifollicular dermal preadipocytes is essential to the pathophysiology of acne</article-title>. <source>Sci Transl Med</source>. <year>2022</year>
<month>Feb</month>
<day>16</day>;<volume>14</volume>(<issue>632</issue>):<fpage>eabh1478</fpage>.<pub-id pub-id-type="pmid">35171653</pub-id>
</mixed-citation></ref><ref id="R17"><label>17.</label><mixed-citation publication-type="journal"><name><surname>Deng</surname><given-names>M</given-names></name>, <name><surname>Guerrero-Juarez</surname><given-names>CF</given-names></name>, <name><surname>Sheng</surname><given-names>X</given-names></name>, <name><surname>Xu</surname><given-names>J</given-names></name>, <name><surname>Wu</surname><given-names>X</given-names></name>, <name><surname>Yao</surname><given-names>K</given-names></name>, <etal/>
<article-title>Lepr+ mesenchymal cells sense diet to modulate intestinal stem/progenitor cells via Leptin-Igf1 axis</article-title>. <source>Cell Res</source>. <year>2022</year>
<month>Jul</month>;<volume>32</volume>(<issue>7</issue>):<fpage>670</fpage>&#x02013;<lpage>86</lpage>.<pub-id pub-id-type="pmid">35296796</pub-id>
</mixed-citation></ref><ref id="R18"><label>18.</label><mixed-citation publication-type="journal"><name><surname>Song</surname><given-names>Y</given-names></name>, <name><surname>Guerrero-Juarez</surname><given-names>CF</given-names></name>, <name><surname>Chen</surname><given-names>Z</given-names></name>, <name><surname>Tang</surname><given-names>Y</given-names></name>, <name><surname>Ma</surname><given-names>X</given-names></name>, <name><surname>Lv</surname><given-names>C</given-names></name>, <etal/>
<article-title>The Msi1-mTOR pathway drives the pathogenesis of mammary and extramammary Paget&#x02019;s disease</article-title>. <source>Cell Res</source>. <year>2020</year>
<month>Oct</month>;<volume>30</volume>(<issue>10</issue>):<fpage>854</fpage>&#x02013;<lpage>72</lpage>.<pub-id pub-id-type="pmid">32457396</pub-id>
</mixed-citation></ref><ref id="R19"><label>19.</label><mixed-citation publication-type="journal"><name><surname>Deng</surname><given-names>M</given-names></name>, <name><surname>Odhiambo</surname><given-names>WO</given-names></name>, <name><surname>Gu</surname><given-names>Y</given-names></name>, <name><surname>Pellegrini</surname><given-names>M</given-names></name>, <name><surname>Modlin</surname><given-names>RL</given-names></name>, <name><surname>Agak</surname><given-names>GW</given-names></name>. <article-title>072 Mapping cell communication dynamics in acne: Insights from single-cell and spatial transcriptomics</article-title>. <source>Journal of Investigative Dermatology</source>. <year>2024</year>
<month>Aug</month>
<day>1</day>;<volume>144</volume>(<issue>8</issue>):<fpage>S13</fpage>.</mixed-citation></ref><ref id="R20"><label>20.</label><mixed-citation publication-type="journal"><name><surname>Bi</surname><given-names>X</given-names></name>, <name><surname>Lou</surname><given-names>P</given-names></name>, <name><surname>Song</surname><given-names>Y</given-names></name>, <name><surname>Sheng</surname><given-names>X</given-names></name>, <name><surname>Liu</surname><given-names>R</given-names></name>, <name><surname>Deng</surname><given-names>M</given-names></name>, <etal/>
<article-title>Msi1 promotes breast cancer metastasis by regulating invadopodia-mediated extracellular matrix degradation via the Timp3-Mmp9 pathway</article-title>. <source>Oncogene</source>. <year>2021</year>
<month>Jul</month>;<volume>40</volume>(<issue>29</issue>):<fpage>4832</fpage>&#x02013;<lpage>45</lpage>.<pub-id pub-id-type="pmid">34155343</pub-id>
</mixed-citation></ref><ref id="R21"><label>21.</label><mixed-citation publication-type="journal"><name><surname>Do</surname><given-names>TH</given-names></name>, <name><surname>Ma</surname><given-names>F</given-names></name>, <name><surname>Andrade</surname><given-names>PR</given-names></name>, <name><surname>Teles</surname><given-names>R</given-names></name>, <name><surname>de Andrade Silva</surname><given-names>BJ</given-names></name>, <name><surname>Hu</surname><given-names>C</given-names></name>, <etal/>
<article-title>TREM2 macrophages induced by human lipids drive inflammation in acne lesions</article-title>. <source>Sci Immunol</source>. <year>2022</year>
<month>Jul</month>
<day>22</day>;<volume>7</volume>(<issue>73</issue>):<fpage>eabo2787</fpage>.<pub-id pub-id-type="pmid">35867799</pub-id>
</mixed-citation></ref><ref id="R22"><label>22.</label><mixed-citation publication-type="journal"><name><surname>Ma</surname><given-names>F</given-names></name>, <name><surname>Hughes</surname><given-names>TK</given-names></name>, <name><surname>Teles</surname><given-names>RMB</given-names></name>, <name><surname>Andrade</surname><given-names>PR</given-names></name>, <name><surname>de Andrade Silva</surname><given-names>BJ</given-names></name>, <name><surname>Plazyo</surname><given-names>O</given-names></name>, <etal/>
<article-title>The cellular architecture of the antimicrobial response network in human leprosy granulomas</article-title>. <source>Nat Immunol</source>. <year>2021</year>
<month>Jul</month>;<volume>22</volume>(<issue>7</issue>):<fpage>839</fpage>&#x02013;<lpage>50</lpage>.<pub-id pub-id-type="pmid">34168371</pub-id>
</mixed-citation></ref><ref id="R23"><label>23.</label><mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>J</given-names></name>, <name><surname>Ochoa</surname><given-names>MT</given-names></name>, <name><surname>Krutzik</surname><given-names>SR</given-names></name>, <name><surname>Takeuchi</surname><given-names>O</given-names></name>, <name><surname>Uematsu</surname><given-names>S</given-names></name>, <name><surname>Legaspi</surname><given-names>AJ</given-names></name>, <etal/>
<article-title>Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses</article-title>. <source>J Immunol</source>. <year>2002</year>
<month>Aug</month>
<day>1</day>;<volume>169</volume>(<issue>3</issue>):<fpage>1535</fpage>&#x02013;<lpage>41</lpage>.<pub-id pub-id-type="pmid">12133981</pub-id>
</mixed-citation></ref><ref id="R24"><label>24.</label><mixed-citation publication-type="journal"><name><surname>Suvanprakorn</surname><given-names>P</given-names></name>, <name><surname>Tongyen</surname><given-names>T</given-names></name>, <name><surname>Prakhongcheep</surname><given-names>O</given-names></name>, <name><surname>Laoratthaphong</surname><given-names>P</given-names></name>, <name><surname>Chanvorachote</surname><given-names>P</given-names></name>. <article-title>Establishment of an Anti-acne Vulgaris Evaluation Method Based on TLR2 and TLR4-mediated Interleukin-8</article-title>
<source>Production. In Vivo</source>. <year>2019</year>
<month>Nov-Dec</month>;<volume>33</volume>(<issue>6</issue>):<fpage>1929</fpage>&#x02013;<lpage>34</lpage>.<pub-id pub-id-type="pmid">31662521</pub-id>
</mixed-citation></ref><ref id="R25"><label>25.</label><mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>F</given-names></name>, <name><surname>Lin</surname><given-names>L</given-names></name>, <name><surname>He</surname><given-names>Y</given-names></name>, <name><surname>Sun</surname><given-names>G</given-names></name>, <name><surname>Dong</surname><given-names>D</given-names></name>, <name><surname>Wu</surname><given-names>B</given-names></name>. <article-title>BMAL1 regulates Propionibacterium acnes-induced skin inflammation via REV-ERB&#x003b1; in mice</article-title>. <source>Int J Biol Sci</source>. <year>2022</year>
<month>Mar</month>
<day>21</day>;<volume>18</volume>(<issue>6</issue>):<fpage>2597</fpage>&#x02013;<lpage>608</lpage>.<pub-id pub-id-type="pmid">35414779</pub-id>
</mixed-citation></ref><ref id="R26"><label>26.</label><mixed-citation publication-type="journal"><name><surname>Kheshvadjian</surname><given-names>AR</given-names></name>, <name><surname>Qin</surname><given-names>M</given-names></name>, <name><surname>Gilliland</surname><given-names>SP</given-names></name>, <name><surname>Deng</surname><given-names>M</given-names></name>, <name><surname>Odhiambo</surname><given-names>WO</given-names></name>, <name><surname>To</surname><given-names>T</given-names></name>, <etal/>
<article-title>448 Silencing the storm: siRNA-mediated knockdown of S100A8/A9 diminishes the inflammatory response in sebocytes exposed to cutibacterium acnes</article-title>. <source>Journal of Investigative Dermatology</source>. <year>2024</year>
<month>Aug</month>
<day>1</day>;<volume>144</volume>(<issue>8</issue>):<fpage>S78</fpage>.</mixed-citation></ref><ref id="R27"><label>27.</label><mixed-citation publication-type="journal"><name><surname>Qin</surname><given-names>M</given-names></name>, <name><surname>Pirouz</surname><given-names>A</given-names></name>, <name><surname>Kim</surname><given-names>MH</given-names></name>, <name><surname>Krutzik</surname><given-names>SR</given-names></name>, <name><surname>Garb&#x000e1;n</surname><given-names>HJ</given-names></name>, <name><surname>Kim</surname><given-names>J</given-names></name>. <article-title>Propionibacterium acnes Induces IL-1&#x003b2; secretion via the NLRP3 inflammasome in human monocytes</article-title>. <source>J Invest Dermatol</source>. <year>2014</year>
<month>Feb</month>;<volume>134</volume>(<issue>2</issue>):<fpage>381</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">23884315</pub-id>
</mixed-citation></ref><ref id="R28"><label>28.</label><mixed-citation publication-type="journal"><name><surname>Caillon</surname><given-names>F</given-names></name>, <name><surname>O&#x02019;Connell</surname><given-names>M</given-names></name>, <name><surname>Eady</surname><given-names>EA</given-names></name>, <name><surname>Jenkins</surname><given-names>GR</given-names></name>, <name><surname>Cove</surname><given-names>JH</given-names></name>, <name><surname>Layton</surname><given-names>AM</given-names></name>, <name><surname>Mountford</surname><given-names>AP</given-names></name>. <article-title>Interleukin-10 secretion from CD14+ peripheral blood mononuclear cells is downregulated in patients with acne vulgaris</article-title>. <source>Br J Dermatol</source>. <year>2010</year>
<month>Feb</month>
<day>1</day>;<volume>162</volume>(<issue>2</issue>):<fpage>296</fpage>&#x02013;<lpage>303</lpage>.<pub-id pub-id-type="pmid">19796181</pub-id>
</mixed-citation></ref><ref id="R29"><label>29.</label><mixed-citation publication-type="journal"><name><surname>Agak</surname><given-names>GW</given-names></name>, <name><surname>Qin</surname><given-names>M</given-names></name>, <name><surname>Nobe</surname><given-names>J</given-names></name>, <name><surname>Kim</surname><given-names>MH</given-names></name>, <name><surname>Krutzik</surname><given-names>SR</given-names></name>, <name><surname>Tristan</surname><given-names>GR</given-names></name>, <etal/>
<article-title>Propionibacterium acnes Induces an IL-17 Response in Acne Vulgaris that Is Regulated by Vitamin A and Vitamin D</article-title>. <source>J Invest Dermatol</source>. <year>2014</year>
<month>Feb</month>;<volume>134</volume>(<issue>2</issue>):<fpage>366</fpage>&#x02013;<lpage>73</lpage>.<pub-id pub-id-type="pmid">23924903</pub-id>
</mixed-citation></ref><ref id="R30"><label>30.</label><mixed-citation publication-type="journal"><name><surname>Kelh&#x000e4;l&#x000e4;</surname><given-names>HL</given-names></name>, <name><surname>Palatsi</surname><given-names>R</given-names></name>, <name><surname>Fyhrquist</surname><given-names>N</given-names></name>, <name><surname>Lehtim&#x000e4;ki</surname><given-names>S</given-names></name>, <name><surname>V&#x000e4;yrynen</surname><given-names>JP</given-names></name>, <name><surname>Kallioinen</surname><given-names>M</given-names></name>, <etal/>
<article-title>IL-17/Th17 pathway is activated in acne lesions</article-title>. <source>PLoS One</source>. <year>2014</year>
<month>Aug</month>
<day>25</day>;<volume>9</volume>(<issue>8</issue>):<fpage>e105238</fpage>.<pub-id pub-id-type="pmid">25153527</pub-id>
</mixed-citation></ref><ref id="R31"><label>31.</label><mixed-citation publication-type="journal"><name><surname>Agak</surname><given-names>GW</given-names></name>, <name><surname>Kao</surname><given-names>S</given-names></name>, <name><surname>Ouyang</surname><given-names>K</given-names></name>, <name><surname>Qin</surname><given-names>M</given-names></name>, <name><surname>Moon</surname><given-names>D</given-names></name>, <name><surname>Butt</surname><given-names>A</given-names></name>, <etal/>
<article-title>Phenotype and Antimicrobial Activity of Th17 Cells Induced by Propionibacterium acnes Strains Associated with Healthy and Acne Skin</article-title>. <source>J Invest Dermatol</source>. <year>2018</year>
<month>Feb</month>;<volume>138</volume>(<issue>2</issue>):<fpage>316</fpage>&#x02013;<lpage>24</lpage>.<pub-id pub-id-type="pmid">28864077</pub-id>
</mixed-citation></ref><ref id="R32"><label>32.</label><mixed-citation publication-type="journal"><name><surname>Agak</surname><given-names>GW</given-names></name>, <name><surname>Mouton</surname><given-names>A</given-names></name>, <name><surname>Teles</surname><given-names>RM</given-names></name>, <name><surname>Weston</surname><given-names>T</given-names></name>, <name><surname>Morselli</surname><given-names>M</given-names></name>, <name><surname>Andrade</surname><given-names>PR</given-names></name>, <etal/>
<article-title>Extracellular traps released by antimicrobial TH17 cells contribute to host defense</article-title>. <source>J Clin Invest</source>. <year>2021</year>
<month>Jan</month>
<day>19</day>;<volume>131</volume>(<issue>2</issue>):<fpage>e141594</fpage>.<pub-id pub-id-type="pmid">33211671</pub-id>
</mixed-citation></ref><ref id="R33"><label>33.</label><mixed-citation publication-type="journal"><name><surname>Zeng</surname><given-names>R</given-names></name>, <name><surname>Xu</surname><given-names>H</given-names></name>, <name><surname>Liu</surname><given-names>Y</given-names></name>, <name><surname>Du</surname><given-names>L</given-names></name>, <name><surname>Duan</surname><given-names>Z</given-names></name>, <name><surname>Tong</surname><given-names>J</given-names></name>, <name><surname>He</surname><given-names>Y</given-names></name>, <name><surname>Chen</surname><given-names>Q</given-names></name>, <name><surname>Chen</surname><given-names>X</given-names></name>, <name><surname>Li</surname><given-names>M</given-names></name>. <article-title>miR-146a Inhibits Biofilm-Derived Cutibacterium acnes-Induced Inflammatory Reactions in Human Keratinocytes</article-title>. <source>J Invest Dermatol</source>. <year>2019</year>
<month>Dec</month>;<volume>139</volume>(<issue>12</issue>):<fpage>2488</fpage>&#x02013;<lpage>96.e4</lpage>.<pub-id pub-id-type="pmid">31194941</pub-id>
</mixed-citation></ref><ref id="R34"><label>34.</label><mixed-citation publication-type="journal"><name><surname>Xia</surname><given-names>X</given-names></name>, <name><surname>Li</surname><given-names>Z</given-names></name>, <name><surname>Liu</surname><given-names>K</given-names></name>, <name><surname>Wu</surname><given-names>Y</given-names></name>, <name><surname>Jiang</surname><given-names>D</given-names></name>, <name><surname>Lai</surname><given-names>Y</given-names></name>. <article-title>Staphylococcal LTA-Induced miR-143 Inhibits Propionibacterium acnes-Mediated Inflammatory Response in Skin</article-title>. <source>J Invest Dermatol</source>. <year>2016</year>
<month>Mar</month>;<volume>136</volume>(<issue>3</issue>):<fpage>621</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="pmid">26739093</pub-id>
</mixed-citation></ref><ref id="R35"><label>35.</label><mixed-citation publication-type="journal"><name><surname>Zhou</surname><given-names>M</given-names></name>, <name><surname>Liu</surname><given-names>Y</given-names></name>, <name><surname>Xu</surname><given-names>H</given-names></name>, <name><surname>Chen</surname><given-names>X</given-names></name>, <name><surname>Zheng</surname><given-names>N</given-names></name>, <name><surname>Duan</surname><given-names>Z</given-names></name>, <etal/>
<article-title>YTHDC1-Modified m6A Methylation of Hsa_circ_0102678 Promotes Keratinocyte Inflammation Induced by Cutibacterium acnes Biofilm through Regulating miR-146a/TRAF6 and IRAK1 Axis</article-title>. <source>J Innate Immun</source>. <year>2023</year>;<volume>15</volume>(<issue>1</issue>):<fpage>822</fpage>&#x02013;<lpage>35</lpage>.<pub-id pub-id-type="pmid">37903473</pub-id>
</mixed-citation></ref><ref id="R36"><label>36.</label><mixed-citation publication-type="journal"><name><surname>Erdei</surname><given-names>L</given-names></name>, <name><surname>Bolla</surname><given-names>BS</given-names></name>, <name><surname>Boz&#x000f3;</surname><given-names>R</given-names></name>, <name><surname>Tax</surname><given-names>G</given-names></name>, <name><surname>Urb&#x000e1;n</surname><given-names>E</given-names></name>, <name><surname>Kem&#x000e9;ny</surname><given-names>L</given-names></name>, <etal/>
<article-title>TNIP1 Regulates Cutibacterium acnes-Induced Innate Immune Functions in Epidermal Keratinocytes</article-title>. <source>Front Immunol</source>. <year>2018</year>
<month>Sep</month>
<day>24</day>;<volume>9</volume>:<fpage>2155</fpage>.<pub-id pub-id-type="pmid">30319618</pub-id>
</mixed-citation></ref><ref id="R37"><label>37.</label><mixed-citation publication-type="journal"><name><surname>Erdei</surname><given-names>L</given-names></name>, <name><surname>Bolla</surname><given-names>BS</given-names></name>, <name><surname>Boz&#x000f3;</surname><given-names>R</given-names></name>, <name><surname>Tax</surname><given-names>G</given-names></name>, <name><surname>Urb&#x000e1;n</surname><given-names>E</given-names></name>, <name><surname>Buri&#x000e1;n</surname><given-names>K</given-names></name>, <etal/>
<article-title>Tumour Necrosis Factor Alpha-induced Protein 3 Negatively Regulates Cutibacterium acnes-induced Innate Immune Events in Epidermal Keratinocytes</article-title>. <source>Acta Derm Venereol</source>. <year>2021</year>
<month>Jan</month>
<day>13</day>;<volume>101</volume>(<issue>1</issue>):<fpage>adv00369</fpage>.<pub-id pub-id-type="pmid">33241420</pub-id>
</mixed-citation></ref><ref id="R38"><label>38.</label><mixed-citation publication-type="journal"><name><surname>Yang</surname><given-names>S</given-names></name>, <name><surname>Fang</surname><given-names>F</given-names></name>, <name><surname>Yu</surname><given-names>X</given-names></name>, <name><surname>Yang</surname><given-names>C</given-names></name>, <name><surname>Zhang</surname><given-names>X</given-names></name>, <name><surname>Wang</surname><given-names>L</given-names></name>, <etal/>
<article-title>Knockdown of H19 Inhibits the Pathogenesis of Acne Vulgaris by Targeting the miR-196a/TLR2/NF-&#x003ba;B Axis</article-title>. <source>Inflammation</source>. <year>2020</year>
<month>Oct</month>;<volume>43</volume>(<issue>5</issue>):<fpage>1936</fpage>&#x02013;<lpage>47</lpage>.<pub-id pub-id-type="pmid">32524335</pub-id>
</mixed-citation></ref><ref id="R39"><label>39.</label><mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>SE</given-names></name>, <name><surname>Kim</surname><given-names>JM</given-names></name>, <name><surname>Jeong</surname><given-names>SK</given-names></name>, <name><surname>Jeon</surname><given-names>JE</given-names></name>, <name><surname>Yoon</surname><given-names>HJ</given-names></name>, <name><surname>Jeong</surname><given-names>MK</given-names></name>, <etal/>
<article-title>Protease-activated receptor-2 mediates the expression of inflammatory cytokines, antimicrobial peptides, and matrix metalloproteinases in keratinocytes in response to Propionibacterium acnes</article-title>. <source>Arch Dermatol Res</source>. <year>2010</year>
<month>Dec</month>;<volume>302</volume>(<issue>10</issue>):<fpage>745</fpage>&#x02013;<lpage>56</lpage>.<pub-id pub-id-type="pmid">20697725</pub-id>
</mixed-citation></ref><ref id="R40"><label>40.</label><mixed-citation publication-type="journal"><name><surname>Wei</surname><given-names>Z</given-names></name>, <name><surname>Gao</surname><given-names>M</given-names></name>, <name><surname>Liu</surname><given-names>Y</given-names></name>, <name><surname>Zeng</surname><given-names>R</given-names></name>, <name><surname>Liu</surname><given-names>J</given-names></name>, <name><surname>Sun</surname><given-names>S</given-names></name>, <etal/>
<article-title>TRPV3 promotes sebocyte inflammation via transcriptional modulating TLR2 in acne</article-title>. <source>Biochim Biophys Acta Mol Basis Dis</source>. <year>2024</year>
<month>Jun</month>;<volume>1870</volume>(<issue>5</issue>):<fpage>167195</fpage>.<pub-id pub-id-type="pmid">38648901</pub-id>
</mixed-citation></ref><ref id="R41"><label>41.</label><mixed-citation publication-type="journal"><name><surname>Cao</surname><given-names>J</given-names></name>, <name><surname>Xu</surname><given-names>M</given-names></name>, <name><surname>Zhu</surname><given-names>L</given-names></name>, <name><surname>Xiao</surname><given-names>S</given-names></name>. <article-title>Viaminate Inhibits Propionibacterium Acnes-induced Abnormal Proliferation and Keratinization of HaCat Cells by Regulating the S100A8/S100A9- MAPK Cascade</article-title>. <source>Curr Drug Targets</source>. <year>2023</year>;<volume>24</volume>(<issue>13</issue>):<fpage>1055</fpage>&#x02013;<lpage>65</lpage>.<pub-id pub-id-type="pmid">37861037</pub-id>
</mixed-citation></ref><ref id="R42"><label>42.</label><mixed-citation publication-type="journal"><name><surname>Baker</surname><given-names>M</given-names></name>, <name><surname>Mackenzie</surname><given-names>IR</given-names></name>, <name><surname>Pickering-Brown</surname><given-names>SM</given-names></name>, <name><surname>Gass</surname><given-names>J</given-names></name>, <name><surname>Rademakers</surname><given-names>R</given-names></name>, <name><surname>Lindholm</surname><given-names>C</given-names></name>, <etal/>
<article-title>Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17</article-title>. <source>Nature</source>. <year>2006</year>
<month>Aug</month>
<day>24</day>;<volume>442</volume>(<issue>7105</issue>):<fpage>916</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">16862116</pub-id>
</mixed-citation></ref><ref id="R43"><label>43.</label><mixed-citation publication-type="journal"><name><surname>Nielsen</surname><given-names>SR</given-names></name>, <name><surname>Quaranta</surname><given-names>V</given-names></name>, <name><surname>Linford</surname><given-names>A</given-names></name>, <name><surname>Emeagi</surname><given-names>P</given-names></name>, <name><surname>Rainer</surname><given-names>C</given-names></name>, <name><surname>Santos</surname><given-names>A</given-names></name>, <etal/>
<article-title>Macrophage-secreted granulin supports pancreatic cancer metastasis by inducing liver fibrosis</article-title>. <source>Nat Cell Biol</source>. <year>2016</year>
<month>May</month>;<volume>18</volume>(<issue>5</issue>):<fpage>549</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="pmid">27088855</pub-id>
</mixed-citation></ref><ref id="R44"><label>44.</label><mixed-citation publication-type="journal"><name><surname>Gan</surname><given-names>WL</given-names></name>, <name><surname>Ren</surname><given-names>X</given-names></name>, <name><surname>Ng</surname><given-names>VHE</given-names></name>, <name><surname>Ng</surname><given-names>L</given-names></name>, <name><surname>Song</surname><given-names>Y</given-names></name>, <name><surname>Tano</surname><given-names>V</given-names></name>, <etal/>
<article-title>Hepatocyte-macrophage crosstalk via the PGRN-EGFR axis modulates ADAR1-mediated immunity in the liver</article-title>. <source>Cell Rep</source>. <year>2024</year>
<month>Jul</month>
<day>23</day>;<volume>43</volume>(<issue>7</issue>):<fpage>114400</fpage>.<pub-id pub-id-type="pmid">38935501</pub-id>
</mixed-citation></ref><ref id="R45"><label>45.</label><mixed-citation publication-type="journal"><name><surname>Kurokawa</surname><given-names>I</given-names></name>, <name><surname>Danby</surname><given-names>FW</given-names></name>, <name><surname>Ju</surname><given-names>Q</given-names></name>, <name><surname>Wang</surname><given-names>X</given-names></name>, <name><surname>Xiang</surname><given-names>LF</given-names></name>, <name><surname>Xia</surname><given-names>L</given-names></name>, <etal/>
<article-title>New developments in our understanding of acne pathogenesis and treatment</article-title>. <source>Exp Dermatol</source>. <year>2009</year>
<month>Oct</month>;<volume>18</volume>(<issue>10</issue>):<fpage>821</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="pmid">19555434</pub-id>
</mixed-citation></ref><ref id="R46"><label>46.</label><mixed-citation publication-type="journal"><name><surname>Yu</surname><given-names>XQ</given-names></name>, <name><surname>Mao</surname><given-names>JZ</given-names></name>, <name><surname>Yang</surname><given-names>SY</given-names></name>, <name><surname>Wang</surname><given-names>L</given-names></name>, <name><surname>Yang</surname><given-names>CZ</given-names></name>, <name><surname>Huang</surname><given-names>L</given-names></name>, <etal/>
<article-title>Autocrine IL-8 Contributes to Propionibacterium Acnes-induced Proliferation and Differentiation of HaCaT Cells via AKT/FOXO1/ Autophagy</article-title>. <source>Curr Med Sci</source>. <year>2024</year>
<month>Oct</month>;<volume>44</volume>(<issue>5</issue>):<fpage>1058</fpage>&#x02013;<lpage>65</lpage>.<pub-id pub-id-type="pmid">39196519</pub-id>
</mixed-citation></ref><ref id="R47"><label>47.</label><mixed-citation publication-type="journal"><name><surname>Isard</surname><given-names>O</given-names></name>, <name><surname>Knol</surname><given-names>AC</given-names></name>, <name><surname>Ari&#x000e8;s</surname><given-names>MF</given-names></name>, <name><surname>Nguyen</surname><given-names>JM</given-names></name>, <name><surname>Khammari</surname><given-names>A</given-names></name>, <name><surname>Castex-Rizzi</surname><given-names>N</given-names></name>, <etal/>
<article-title>Propionibacterium acnes activates the IGF-1/IGF-1R system in the epidermis and induces keratinocyte proliferation</article-title>. <source>J Invest Dermatol</source>. <year>2011</year>
<month>Jan</month>;<volume>131</volume>(<issue>1</issue>):<fpage>59</fpage>&#x02013;<lpage>66</lpage>.<pub-id pub-id-type="pmid">20927124</pub-id>
</mixed-citation></ref><ref id="R48"><label>48.</label><mixed-citation publication-type="journal"><name><surname>Shi</surname><given-names>G</given-names></name>, <name><surname>Liao</surname><given-names>PY</given-names></name>, <name><surname>Cai</surname><given-names>XL</given-names></name>, <name><surname>Pi</surname><given-names>XX</given-names></name>, <name><surname>Zhang</surname><given-names>MF</given-names></name>, <name><surname>Li</surname><given-names>SJ</given-names></name>, <etal/>
<article-title>FoxO1 enhances differentiation and apoptosis in human primary keratinocytes</article-title>. <source>Exp Dermatol</source>. <year>2018</year>
<month>Nov</month>;<volume>27</volume>(<issue>11</issue>):<fpage>1254</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="pmid">30144329</pub-id>
</mixed-citation></ref><ref id="R49"><label>49.</label><mixed-citation publication-type="journal"><name><surname>Feng</surname><given-names>Y</given-names></name>, <name><surname>Li</surname><given-names>J</given-names></name>, <name><surname>Mo</surname><given-names>X</given-names></name>, <name><surname>Ju</surname><given-names>Q</given-names></name>. <article-title>Macrophages in acne vulgaris: mediating phagocytosis, inflammation, scar formation, and therapeutic implications</article-title>. <source>Front Immunol</source>. <year>2024</year>
<month>Mar</month>
<day>14</day>;<volume>15</volume>:<fpage>1355455</fpage>.<pub-id pub-id-type="pmid">38550588</pub-id>
</mixed-citation></ref><ref id="R50"><label>50.</label><mixed-citation publication-type="journal"><name><surname>Takahashi</surname><given-names>M</given-names></name>, <name><surname>Umehara</surname><given-names>Y</given-names></name>, <name><surname>Yue</surname><given-names>H</given-names></name>, <name><surname>Trujillo-Paez</surname><given-names>JV</given-names></name>, <name><surname>Peng</surname><given-names>G</given-names></name>, <name><surname>Nguyen</surname><given-names>HLT</given-names></name>, <etal/>
<article-title>The Antimicrobial Peptide Human &#x003b2;-Defensin-3 Accelerates Wound Healing by Promoting Angiogenesis, Cell Migration, and Proliferation Through the FGFR/JAK2/STAT3 Signaling Pathway</article-title>. <source>Front Immunol</source>. <year>2021</year>
<month>Sep</month>
<day>14</day>;<volume>12</volume>:<fpage>712781</fpage>.<pub-id pub-id-type="pmid">34594328</pub-id>
</mixed-citation></ref><ref id="R51"><label>51.</label><mixed-citation publication-type="journal"><name><surname>Niyonsaba</surname><given-names>F</given-names></name>, <name><surname>Ushio</surname><given-names>H</given-names></name>, <name><surname>Nakano</surname><given-names>N</given-names></name>, <name><surname>Ng</surname><given-names>W</given-names></name>, <name><surname>Sayama</surname><given-names>K</given-names></name>, <name><surname>Hashimoto</surname><given-names>K</given-names></name>, <etal/>
<article-title>Antimicrobial peptides human beta-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines</article-title>. <source>J Invest Dermatol</source>. <year>2007</year>
<month>Mar</month>;<volume>127</volume>(<issue>3</issue>):<fpage>594</fpage>&#x02013;<lpage>604</lpage>.<pub-id pub-id-type="pmid">17068477</pub-id>
</mixed-citation></ref><ref id="R52"><label>52.</label><mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>C</given-names></name>, <name><surname>Chinnappan</surname><given-names>M</given-names></name>, <name><surname>Prestwood</surname><given-names>CA</given-names></name>, <name><surname>Edwards</surname><given-names>M</given-names></name>, <name><surname>Artami</surname><given-names>M</given-names></name>, <name><surname>Thompson</surname><given-names>BM</given-names></name>, <etal/>
<article-title>Interleukins 4 and 13 drive lipid abnormalities in skin cells through regulation of sex steroid hormone synthesis</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2021</year>
<month>Sep</month>
<day>21</day>;<volume>118</volume>(<issue>38</issue>):<fpage>e2100749118</fpage>.<pub-id pub-id-type="pmid">34521750</pub-id>
</mixed-citation></ref><ref id="R53"><label>53.</label><mixed-citation publication-type="journal"><name><surname>Sander</surname><given-names>N</given-names></name>, <name><surname>St&#x000f6;lzl</surname><given-names>D</given-names></name>, <name><surname>Fonfara</surname><given-names>M</given-names></name>, <name><surname>Hartmann</surname><given-names>J</given-names></name>, <name><surname>Harder</surname><given-names>I</given-names></name>, <name><surname>Suhrkamp</surname><given-names>I</given-names></name>, <etal/>
<article-title>Blockade of interleukin-13 signalling improves skin barrier function and biology in patients with moderate-to-severe atopic dermatitis</article-title>. <source>Br J Dermatol</source>. <year>2024</year>
<month>Aug</month>
<day>14</day>;<volume>191</volume>(<issue>3</issue>):<fpage>344</fpage>&#x02013;<lpage>50</lpage>.<pub-id pub-id-type="pmid">38531691</pub-id>
</mixed-citation></ref><ref id="R54"><label>54.</label><mixed-citation publication-type="journal"><name><surname>Oh</surname><given-names>MH</given-names></name>, <name><surname>Oh</surname><given-names>SY</given-names></name>, <name><surname>Yu</surname><given-names>J</given-names></name>, <name><surname>Myers</surname><given-names>AC</given-names></name>, <name><surname>Leonard</surname><given-names>WJ</given-names></name>, <name><surname>Liu</surname><given-names>YJ</given-names></name>, <etal/>
<article-title>IL-13 induces skin fibrosis in atopic dermatitis by thymic stromal lymphopoietin</article-title>. <source>J Immunol</source>. <year>2011</year>
<month>Jun</month>
<day>15</day>;<volume>186</volume>(<issue>12</issue>):<fpage>7232</fpage>&#x02013;<lpage>42</lpage>.<pub-id pub-id-type="pmid">21576506</pub-id>
</mixed-citation></ref><ref id="R55"><label>55.</label><mixed-citation publication-type="journal"><name><surname>Blauvelt</surname><given-names>A</given-names></name>, <name><surname>de Bruin-Weller</surname><given-names>M</given-names></name>, <name><surname>Gooderham</surname><given-names>M</given-names></name>, <name><surname>Cather</surname><given-names>JC</given-names></name>, <name><surname>Weisman</surname><given-names>J</given-names></name>, <name><surname>Pariser</surname><given-names>D</given-names></name>, <etal/>
<article-title>Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial</article-title>. <source>Lancet</source>. <year>2017</year>
<month>Jun</month>
<day>10</day>;<volume>389</volume>(<issue>10086</issue>):<fpage>2287</fpage>&#x02013;<lpage>303</lpage>.<pub-id pub-id-type="pmid">28478972</pub-id>
</mixed-citation></ref><ref id="R56"><label>56.</label><mixed-citation publication-type="journal"><name><surname>Castro</surname><given-names>M</given-names></name>, <name><surname>Corren</surname><given-names>J</given-names></name>, <name><surname>Pavord</surname><given-names>ID</given-names></name>, <name><surname>Maspero</surname><given-names>J</given-names></name>, <name><surname>Wenzel</surname><given-names>S</given-names></name>, <name><surname>Rabe</surname><given-names>KF</given-names></name>, <etal/>
<article-title>Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma</article-title>. <source>N Engl J Med</source>. <year>2018</year>
<month>Jun</month>
<day>28</day>;<volume>378</volume>(<issue>26</issue>):<fpage>2486</fpage>&#x02013;<lpage>96</lpage>.<pub-id pub-id-type="pmid">29782217</pub-id>
</mixed-citation></ref><ref id="R57"><label>57.</label><mixed-citation publication-type="journal"><name><surname>Bachert</surname><given-names>C</given-names></name>, <name><surname>Han</surname><given-names>JK</given-names></name>, <name><surname>Desrosiers</surname><given-names>M</given-names></name>, <name><surname>Hellings</surname><given-names>PW</given-names></name>, <name><surname>Amin</surname><given-names>N</given-names></name>, <name><surname>Lee</surname><given-names>SE</given-names></name>, <etal/>
<article-title>Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, doubleblind, placebo-controlled, parallel-group phase 3 trials</article-title>. <source>Lancet</source>. <year>2019</year>
<month>Nov</month>
<day>2</day>;<volume>394</volume>(<issue>10209</issue>):<fpage>1638</fpage>&#x02013;<lpage>50</lpage>.<pub-id pub-id-type="pmid">31543428</pub-id>
</mixed-citation></ref><ref id="R58"><label>58.</label><mixed-citation publication-type="journal"><name><surname>Martin-Blondel</surname><given-names>G</given-names></name>, <name><surname>Brassat</surname><given-names>D</given-names></name>, <name><surname>Bauer</surname><given-names>J</given-names></name>, <name><surname>Lassmann</surname><given-names>H</given-names></name>, <name><surname>Liblau</surname><given-names>RS</given-names></name>. <article-title>CCR5 blockade for neuroinflammatory diseases--beyond control of HIV</article-title>. <source>Nat Rev Neurol</source>. <year>2016</year>
<month>Feb</month>;<volume>12</volume>(<issue>2</issue>):<fpage>95</fpage>&#x02013;<lpage>105</lpage>.<pub-id pub-id-type="pmid">26782333</pub-id>
</mixed-citation></ref><ref id="R59"><label>59.</label><mixed-citation publication-type="journal"><name><surname>Ascef</surname><given-names>BO</given-names></name>, <name><surname>Almeida</surname><given-names>MO</given-names></name>, <name><surname>Medeiros-Ribeiro</surname><given-names>AC</given-names></name>, <name><surname>Oliveira de Andrade</surname><given-names>DC</given-names></name>, <name><surname>Oliveira Junior</surname><given-names>HA</given-names></name>, <name><surname>de So&#x000e1;rez</surname><given-names>PC</given-names></name>. <article-title>Therapeutic Equivalence of Biosimilar and Reference Biologic Drugs in Rheumatoid Arthritis: A Systematic Review and Meta-analysis</article-title>. <source>JAMA Netw Open</source>. <year>2023</year>
<month>May</month>
<day>1</day>;<volume>6</volume>(<issue>5</issue>):<fpage>e2315872</fpage>.<pub-id pub-id-type="pmid">37234004</pub-id>
</mixed-citation></ref><ref id="R60"><label>60.</label><mixed-citation publication-type="journal"><name><surname>den Broeder</surname><given-names>N</given-names></name>, <name><surname>den Broeder</surname><given-names>AA</given-names></name>, <name><surname>Verhoef</surname><given-names>LM</given-names></name>, <name><surname>van den Hoogen</surname><given-names>FHJ</given-names></name>, <name><surname>van der Maas</surname><given-names>A</given-names></name>, <name><surname>van den Bemt</surname><given-names>BJF</given-names></name>. <article-title>Non-Medical Switching from Tocilizumab to Sarilumab in Rheumatoid Arthritis Patients with Low Disease Activity, an Observational Study</article-title>. <source>Clin Pharmacol Ther</source>. <year>2023</year>
<month>Oct</month>;<volume>114</volume>(<issue>4</issue>):<fpage>810</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">37429827</pub-id>
</mixed-citation></ref><ref id="R61"><label>61.</label><mixed-citation publication-type="journal"><name><surname>Sanz-Cabanillas</surname><given-names>JL</given-names></name>, <name><surname>G&#x000f3;mez-Garc&#x000ed;a</surname><given-names>F</given-names></name>, <name><surname>G&#x000f3;mez-Arias</surname><given-names>PJ</given-names></name>, <name><surname>Montilla-L&#x000f3;pez</surname><given-names>A</given-names></name>, <name><surname>Gay-Mimbrera</surname><given-names>J</given-names></name>, <name><surname>Ruano</surname><given-names>J</given-names></name>, <etal/>
<article-title>Efficacy and safety of anakinra and canakinumab in PSTPIP1-associated inflammatory diseases: a comprehensive scoping review</article-title>. <source>Front Immunol</source>. <year>2024</year>
<month>Jan</month>
<day>8</day>;<volume>14</volume>:<fpage>1339337</fpage>.<pub-id pub-id-type="pmid">38259483</pub-id>
</mixed-citation></ref><ref id="R62"><label>62.</label><mixed-citation publication-type="journal"><name><surname>Karlsson</surname><given-names>M</given-names></name>, <name><surname>Zhang</surname><given-names>C</given-names></name>, <name><surname>M&#x000e9;ar</surname><given-names>L</given-names></name>, <name><surname>Zhong</surname><given-names>W</given-names></name>, <name><surname>Digre</surname><given-names>A</given-names></name>, <name><surname>Katona</surname><given-names>B</given-names></name>, <etal/>
<article-title>A single-cell type transcriptomics map of human tissues</article-title>. <source>Sci Adv</source>. <year>2021</year>
<month>Jul</month>
<day>28</day>;<volume>7</volume>(<issue>31</issue>):<fpage>eabh2169</fpage>.<pub-id pub-id-type="pmid">34321199</pub-id>
</mixed-citation></ref><ref id="R63"><label>63.</label><mixed-citation publication-type="journal"><name><surname>Mouser</surname><given-names>PE</given-names></name>, <name><surname>Baker</surname><given-names>BS</given-names></name>, <name><surname>Seaton</surname><given-names>ED</given-names></name>, <name><surname>Chu</surname><given-names>AC</given-names></name>. <article-title>Propionibacterium acnes-reactive T helper-1 cells in the skin of patients with acne vulgaris</article-title>. <source>J Invest Dermatol</source>. <year>2003</year>
<month>Nov</month>;<volume>121</volume>(<issue>5</issue>):<fpage>1226</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">14708633</pub-id>
</mixed-citation></ref><ref id="R64"><label>64.</label><mixed-citation publication-type="journal"><name><surname>Schroder</surname><given-names>K</given-names></name>, <name><surname>Hertzog</surname><given-names>PJ</given-names></name>, <name><surname>Ravasi</surname><given-names>T</given-names></name>, <name><surname>Hume</surname><given-names>DA</given-names></name>. <article-title>Interferon-gamma: an overview of signals, mechanisms and functions</article-title>. <source>J Leukoc Biol</source>. <year>2004</year>
<month>Feb</month>;<volume>75</volume>(<issue>2</issue>):<fpage>163</fpage>&#x02013;<lpage>89</lpage>.<pub-id pub-id-type="pmid">14525967</pub-id>
</mixed-citation></ref><ref id="R65"><label>65.</label><mixed-citation publication-type="journal"><name><surname>Vivier</surname><given-names>E</given-names></name>, <name><surname>Raulet</surname><given-names>DH</given-names></name>, <name><surname>Moretta</surname><given-names>A</given-names></name>, <name><surname>Caligiuri</surname><given-names>MA</given-names></name>, <name><surname>Zitvogel</surname><given-names>L</given-names></name>, <name><surname>Lanier</surname><given-names>LL</given-names></name>, <etal/>
<article-title>Innate or adaptive immunity? The example of natural killer cells</article-title>. <source>Science</source>. <year>2011</year>
<month>Jan</month>
<day>7</day>;<volume>331</volume>(<issue>6013</issue>):<fpage>44</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">21212348</pub-id>
</mixed-citation></ref><ref id="R66"><label>66.</label><mixed-citation publication-type="journal"><name><surname>Yu</surname><given-names>Y</given-names></name>, <name><surname>Champer</surname><given-names>J</given-names></name>, <name><surname>Agak</surname><given-names>GW</given-names></name>, <name><surname>Kao</surname><given-names>S</given-names></name>, <name><surname>Modlin</surname><given-names>RL</given-names></name>, <name><surname>Kim</surname><given-names>J</given-names></name>. <article-title>Different Propionibacterium acnes Phylotypes Induce Distinct Immune Responses and Express Unique Surface and Secreted Proteomes</article-title>. <source>J Invest Dermatol</source>. <year>2016</year>
<month>Nov</month>;<volume>136</volume>(<issue>11</issue>):<fpage>2221</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">27377696</pub-id>
</mixed-citation></ref><ref id="R67"><label>67.</label><mixed-citation publication-type="journal"><name><surname>Cai</surname><given-names>C</given-names></name>, <name><surname>Liu</surname><given-names>S</given-names></name>, <name><surname>Liu</surname><given-names>Y</given-names></name>, <name><surname>Huang</surname><given-names>S</given-names></name>, <name><surname>Lu</surname><given-names>S</given-names></name>, <name><surname>Liu</surname><given-names>F</given-names></name>, <etal/>
<article-title>Paeoniflorin mitigates insulin-like growth factor 1-induced lipogenesis and inflammation in human sebocytes by inhibiting the PI3K/Akt/FoxO1 and JAK2/STAT3 signaling pathways</article-title>. <source>Nat Prod Bioprospect</source>. <year>2024</year>
<month>Oct</month>
<day>1</day>;<volume>14</volume>(<issue>1</issue>):<fpage>56</fpage>.<pub-id pub-id-type="pmid">39349732</pub-id>
</mixed-citation></ref></ref-list></back><floats-group><fig position="float" id="F1"><label>Figure 1.</label><caption><title>New potential markers for annotating major skin cell types in transcriptomic data.</title><p id="P39">The chosen five canonical markers (black), ligands (light purple), and receptors (blue-green) are associated with various cell types including endothelial cells, fibroblasts, lymphocytes, myeloid cells, keratinocytes, and smooth muscle cells. Ligands and receptors were validated across two published skin datasets [<xref rid="R22" ref-type="bibr">22</xref>,<xref rid="R62" ref-type="bibr">62</xref>] *For simplicity, only five key canonical markers are included, though we acknowledge that additional markers have been reported in the literature. Due to page limitations, we did not subset these major cell types or list their markers.</p></caption><graphic xlink:href="nihms-2077915-f0001" position="float"/></fig><fig position="float" id="F2"><label>Figure 2.</label><caption><title>Overview of key genes involved in inflammation and hyperkeratinization in acne.</title><p id="P40">The diagram lists genes from immune cells, keratinocytes, and sebocytes participating in these processes. Each circle represents a cell type, with overlapping regions indicating shared gene expression across cell types in acne. The middle overlapping light purple area between inflammation (blue) and hyperkeratinization (yellow) demonstrates that genes from sebocytes and keratinocytes contribute to both inflammation and hyperkeratinization. Genes are color-coded: Upregulated (red), downregulated (green), and unchanged (black).</p></caption><graphic xlink:href="nihms-2077915-f0002" position="float"/></fig><table-wrap position="float" id="T1" orientation="landscape"><label>Table 1.</label><caption><p id="P41">Key genes that participate in inflammation in acne.</p></caption><table frame="box" rules="all"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Gene</th><th align="left" valign="top" rowspan="1" colspan="1">Acne model or cell type</th><th align="left" valign="top" rowspan="1" colspan="1">Expression Change</th><th align="left" valign="top" rowspan="1" colspan="1">Mechanism</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">TLR2 [<xref rid="R23" ref-type="bibr">23</xref>]</td><td align="left" valign="top" rowspan="1" colspan="1">Peritoneal macrophage, RAW 264.7 cell, primary human monocyte</td><td align="left" valign="top" rowspan="1" colspan="1">Upregulated</td><td align="left" valign="top" rowspan="1" colspan="1">Receptor for <italic toggle="yes">C. acnes</italic> and activate NF-&#x003ba;B signaling</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IL-17 [<xref rid="R30" ref-type="bibr">30</xref>,<xref rid="R31" ref-type="bibr">31</xref>]</td><td align="left" valign="top" rowspan="1" colspan="1">Th17 and Th1 cells</td><td align="left" valign="top" rowspan="1" colspan="1">Upregulated</td><td align="left" valign="top" rowspan="1" colspan="1">Promotion of Th17 Cell Differentiation; Induce the expression of three central pro-inflammatory cytokines</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IFN-&#x003b3; [<xref rid="R63" ref-type="bibr">63</xref>]</td><td align="left" valign="top" rowspan="1" colspan="1">CD4<sup>+</sup> T cells</td><td align="left" valign="top" rowspan="1" colspan="1">Upregulated</td><td align="left" valign="top" rowspan="1" colspan="1">Mediate Th1 cell differentiation and response; activate immune cells including natural killer cells and macrophages to present antigens, and release cytokines including IL-12 [<xref rid="R64" ref-type="bibr">64</xref>,<xref rid="R65" ref-type="bibr">65</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IL-10 [<xref rid="R24" ref-type="bibr">24</xref>,<xref rid="R66" ref-type="bibr">66</xref>]</td><td align="left" valign="top" rowspan="1" colspan="1">PBMCs (CD4<sup>+</sup> T cells, Tregs, monocytes)</td><td align="left" valign="top" rowspan="1" colspan="1">Downregulated</td><td align="left" valign="top" rowspan="1" colspan="1">Inhibit macrophage and dendritic cell functions by downregulating antigen presentation as well as the production of IL-12, chemokines, nitric oxide, reactive oxygen species and costimulatory molecules. <italic toggle="yes">C. acnes</italic> strains associated with healthy skin upregulate IL-10 expression</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">GRN [<xref rid="R11" ref-type="bibr">11</xref>]</td><td align="left" valign="top" rowspan="1" colspan="1">TREM2 macrophage</td><td align="left" valign="top" rowspan="1" colspan="1">Upregulated</td><td align="left" valign="top" rowspan="1" colspan="1">Increase the expression of cytokines IL-18 and chemokines CCL5 and CXCL2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IL-1&#x003b2; [<xref rid="R27" ref-type="bibr">27</xref>]</td><td align="left" valign="top" rowspan="1" colspan="1">Primary human monocyte</td><td align="left" valign="top" rowspan="1" colspan="1">Upregulated</td><td align="left" valign="top" rowspan="1" colspan="1">Activate NLRP3 inflammasome</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BMAL1 [<xref rid="R25" ref-type="bibr">25</xref>]</td><td align="left" valign="top" rowspan="1" colspan="1">C57BL/6 mice, RAW264.7 cell, Primary mouse keratinocyte</td><td align="left" valign="top" rowspan="1" colspan="1">Downregulated</td><td align="left" valign="top" rowspan="1" colspan="1">Inhibit NF-&#x003ba;B/NLRP3 axis</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">miR-146a [<xref rid="R33" ref-type="bibr">33</xref>]</td><td align="left" valign="top" rowspan="1" colspan="1">Primary human keratinocyte</td><td align="left" valign="top" rowspan="1" colspan="1">Upregulated</td><td align="left" valign="top" rowspan="1" colspan="1">Activate the TLR2/IRAK1/TRAF6/NF-&#x003ba;B and MAPK pathways.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">miR-143 [<xref rid="R34" ref-type="bibr">34</xref>]</td><td align="left" valign="top" rowspan="1" colspan="1">Tlr2<sup>&#x02212;/&#x02212;</sup> mice and NHEK cell</td><td align="left" valign="top" rowspan="1" colspan="1">Upregulated</td><td align="left" valign="top" rowspan="1" colspan="1">Decrease the stability of TLR2 mRNA and then decreased TLR2 protein</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">hsa_circ_0102678[<xref rid="R35" ref-type="bibr">35</xref>]</td><td align="left" valign="top" rowspan="1" colspan="1">Primary human keratinocyte</td><td align="left" valign="top" rowspan="1" colspan="1">Upregulated</td><td align="left" valign="top" rowspan="1" colspan="1">Regulate miR-146a/TRAF6 and IRAK1 axis</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">TNIP1 [<xref rid="R36" ref-type="bibr">36</xref>]</td><td align="left" valign="top" rowspan="1" colspan="1">HPV-KER and NHEK cell</td><td align="left" valign="top" rowspan="1" colspan="1">Upregulated</td><td align="left" valign="top" rowspan="1" colspan="1">Upregulate the NF-&#x003ba;B, p38, MAPK and JNK pathways</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">TNFAIP3 [<xref rid="R37" ref-type="bibr">37</xref>]</td><td align="left" valign="top" rowspan="1" colspan="1">HPV-KER cell</td><td align="left" valign="top" rowspan="1" colspan="1">Upregulated</td><td align="left" valign="top" rowspan="1" colspan="1">Dually regulate JNK and NF-&#x003ba;B signaling</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PAR-2 [<xref rid="R39" ref-type="bibr">39</xref>]</td><td align="left" valign="top" rowspan="1" colspan="1">HaCaT</td><td align="left" valign="top" rowspan="1" colspan="1">Upregulated</td><td align="left" valign="top" rowspan="1" colspan="1">Regulate the expression of three central pro-inflammatory cytokines, hBD-2, LL-37, MMP-1, &#x02212;2, &#x02212;3, &#x02212;9, and &#x02212;13</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">H19 [<xref rid="R38" ref-type="bibr">38</xref>]</td><td align="left" valign="top" rowspan="1" colspan="1">HaCaT cell</td><td align="left" valign="top" rowspan="1" colspan="1">Upregulated</td><td align="left" valign="top" rowspan="1" colspan="1">Regulate the miR-196a/TLR2/NF-&#x003ba;B Axis.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">TRPV3 [<xref rid="R40" ref-type="bibr">40</xref>]</td><td align="left" valign="top" rowspan="1" colspan="1">Acne mice model and Sebocyte</td><td align="left" valign="top" rowspan="1" colspan="1">Upregulated</td><td align="left" valign="top" rowspan="1" colspan="1">Lead to TLR2 upregulation and downstream NF-&#x003ba;B signaling activation</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">S100A8 [<xref rid="R26" ref-type="bibr">26</xref>]</td><td align="left" valign="top" rowspan="1" colspan="1">Sebocytes</td><td align="left" valign="top" rowspan="1" colspan="1">Upregulated</td><td rowspan="2" align="left" valign="top" colspan="1">Promote the expression level of IL-8 and IL-6</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">S100A9 [<xref rid="R26" ref-type="bibr">26</xref>]</td><td align="left" valign="top" rowspan="1" colspan="1">Sebocytes</td><td align="left" valign="top" rowspan="1" colspan="1">Unchanged</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p id="P42">HPK: Human Primary Keratinocyte; NHEK: Normal Human Epidermal Keratinocytes; HPV-KER: Human Papillomavirus-Immortalized Keratinocyte; PBMCs: Peripheral Blood Mononuclear Cells; Tregs: Regulatory T cells</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T2" orientation="landscape"><label>Table 2.</label><caption><p id="P43">Indicator of inflammation-driven keratinocyte activation.</p></caption><table frame="box" rules="all"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Gene</th><th align="left" valign="top" rowspan="1" colspan="1">Acne model or material used</th><th align="left" valign="top" rowspan="1" colspan="1">Expression Change</th><th align="left" valign="top" rowspan="1" colspan="1">Mechanism</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">S100A8 [<xref rid="R26" ref-type="bibr">26</xref>,<xref rid="R41" ref-type="bibr">41</xref>]</td><td align="left" valign="top" rowspan="1" colspan="1">HaCaT cell</td><td align="left" valign="top" rowspan="1" colspan="1">Upregulated</td><td rowspan="2" align="left" valign="top" colspan="1">Promote inflammation and MAPK pathway</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">S100A9 [<xref rid="R26" ref-type="bibr">26</xref>,<xref rid="R41" ref-type="bibr">41</xref>]</td><td align="left" valign="top" rowspan="1" colspan="1">HaCaT cell</td><td align="left" valign="top" rowspan="1" colspan="1">Upregulated</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IL-8 [<xref rid="R24" ref-type="bibr">24</xref>,<xref rid="R46" ref-type="bibr">46</xref>]</td><td align="left" valign="top" rowspan="1" colspan="1">HaCaT cell</td><td align="left" valign="top" rowspan="1" colspan="1">Upregulated</td><td align="left" valign="top" rowspan="1" colspan="1">Activate inflammation and AKT/FOXO1 axis</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IGF-1/IGF1-R [<xref rid="R47" ref-type="bibr">47</xref>]</td><td align="left" valign="top" rowspan="1" colspan="1">Skin biopsies and NHEK cell</td><td align="left" valign="top" rowspan="1" colspan="1">Upregulated</td><td align="left" valign="top" rowspan="1" colspan="1">Regulate inflammation and induce proliferation of keratinocytes through PI3K/Akt/FoxO1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FoxO1 [<xref rid="R48" ref-type="bibr">48</xref>,<xref rid="R67" ref-type="bibr">67</xref>]</td><td align="left" valign="top" rowspan="1" colspan="1">HPK</td><td align="left" valign="top" rowspan="1" colspan="1">Downregulated</td><td align="left" valign="top" rowspan="1" colspan="1">Regulate inflammation and promote differentiation and apoptosis in HPKs</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IL13RA1 [<xref rid="R11" ref-type="bibr">11</xref>]</td><td align="left" valign="top" rowspan="1" colspan="1">HaCaT cell</td><td align="left" valign="top" rowspan="1" colspan="1">Upregulated</td><td align="left" valign="top" rowspan="1" colspan="1">The ligand IL-13 can be released by mast cells, NK cells, and regulate KRT17, KRT16, and FLG expression.</td></tr></tbody></table></table-wrap></floats-group></article>